Hypercharge to Supply 135 EV Charging Stations to 16 Residential Properties Across British Columbia
Vancouver, British Columbia–(Newsfile Corp. – July 26, 2023) – Hypercharge Networks Corp. (NEO: HC) (OTCQB: HCNWF) (FSE: PB7)…
News
Montecito Medical Acquires Specialized Medical Property in Tennessee
NASHVILLE, Tenn.–(BUSINESS WIRE)–Montecito Medical, a leading acquirer of medical office properties nationwide, has partnered with…
Tigo Energy Inc. to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023 at 4:30 p.m. ET
CAMPBELL, Calif.–(BUSINESS WIRE)–Tigo Energy Inc. (Nasdaq: TYGO) (“Tigo” or the “Company”), a leading provider of…
Rimini Street Announces Expansion and General Availability of Rimini Manage™ Services for SAP Cloud Products
Company already providing mission-critical services to run and manage SAP Business Suite, S/4HANA and cloud…
KPMG and ServiceNow announce expanded commitment to reimagine finance, supply chain, and procurement operations
Commitment includes significant joint investment in new offerings combining AI, low-code capabilities, and deep industry…
G1 Therapeutics to Release Second Quarter 2023 Financial Results and Provide Business Update on August 2, 2023
RESEARCH TRIANGLE PARK, N.C., July 26, 2023 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX),…
G1 Therapeutics to Release Second Quarter 2023 Financial Results and Provide Business Update on August 2, 2023
RESEARCH TRIANGLE PARK, N.C., July 26, 2023 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX),…
Lumos Pharma to Report Second Quarter 2023 Financial Results and Host Conference Call on August 9, 2023
AUSTIN, Texas, July 26, 2023 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company…
Lumos Pharma to Report Second Quarter 2023 Financial Results and Host Conference Call on August 9, 2023
AUSTIN, Texas, July 26, 2023 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company…
Yield10 Bioscience Files Request for Regulatory Status Review under USDA-APHIS’s SECURE Rule Covering Elite Camelina Designed to Produce the EPA Component of Omega-3 Oil
Camelina containing the omega-3 EPA trait Camelina containing the omega-3 EPA trait growing at acre-scale…
Yield10 Bioscience Files Request for Regulatory Status Review under USDA-APHIS’s SECURE Rule Covering Elite Camelina Designed to Produce the EPA Component of Omega-3 Oil
Camelina containing the omega-3 EPA trait Camelina containing the omega-3 EPA trait growing at acre-scale…
Allogene Therapeutics to Report Second Quarter 2023 Financial Results on August 2, 2023
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET SOUTH SAN FRANCISCO, Calif.,…
Allogene Therapeutics to Report Second Quarter 2023 Financial Results on August 2, 2023
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET SOUTH SAN FRANCISCO, Calif.,…
Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023
Live Conference Call and Webcast at 8:30 a.m. ET PRINCETON, N.J., July 26, 2023 (GLOBE…
Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023
Live Conference Call and Webcast at 8:30 a.m. ET PRINCETON, N.J., July 26, 2023 (GLOBE…
LianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA Approval of XDEMVY™ (lotilaner ophthalmic solution) 0.25% for the Treatment of Demodex Blepharitis
SHANGHAI, China and PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) — LianBio’s (Nasdaq: LIAN) partner,…
LianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA Approval of XDEMVY™ (lotilaner ophthalmic solution) 0.25% for the Treatment of Demodex Blepharitis
SHANGHAI, China and PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) — LianBio’s (Nasdaq: LIAN) partner,…
ABVC Signs Term Sheet to Acquire Real Estate Assets for Strategic Investments
FREMONT, CA, July 26, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ:…
ABVC Signs Term Sheet to Acquire Real Estate Assets for Strategic Investments
FREMONT, CA, July 26, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ:…
CorMedix Inc. to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 8, 2023
BERKELEY HEIGHTS, N.J., July 26, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…